Skip to main content
Alessandra Ferrajoli, MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

AlessandraFerrajoliMD

Oncology Houston, TX

Hematologic Oncology

Physician

Are you Dr. Ferrajoli?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 47 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Alessandra Ferrajoli, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Florida, and Oklahoma. She is affiliated with University of Texas M.D. Anderson Cancer Center.

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1998 - 2001
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1995 - 1998
  • University of Perugia Faculty of Medicine
    University of Perugia Faculty of MedicineClass of 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 2000 - 2024
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • L-carnitine and Vitamin B Complex for the Treatment of Pegasparaginase-Induced HyperbilirubinemiaFebruary 2018
  • Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA101) (iFCG) Treatment for First-Line Therapy of Patients with CLL with Mutated IGHV and Without Deletion 17pOctober 2017
  • The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II TrialOctober 2017

Press Mentions

  • Exploring the CLL/Lymphoma Microenvironment to Improve Therapies
    Exploring the CLL/Lymphoma Microenvironment to Improve TherapiesOctober 11th, 2019
  • Cancer Patients with Rare Deadly Brain Infection Treated Successfully with Off-the-Shelf Adoptive T-cell Therapy in Clinical Trial
    Cancer Patients with Rare Deadly Brain Infection Treated Successfully with Off-the-Shelf Adoptive T-cell Therapy in Clinical TrialOctober 11th, 2018
  • [ Inglés] How Does CLL Affect Sinuses and the Skin?
    [ Inglés] How Does CLL Affect Sinuses and the Skin?September 27th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations